Results 141 to 150 of about 6,382 (183)

Adipocyte-specific Mlkl knockout mitigates obesity-induced metabolic dysfunction by enhancing mitochondrial functions

open access: yesCell Death and Disease
Obesity is a global epidemic characterized by chronic low-grade inflammation and metabolic dysfunction, with adipose tissue playing a pivotal role in these processes.
Juliette Tokgozoglu   +21 more
doaj   +1 more source

Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL

open access: yesCell Death & Disease
AbstractNecroptosis is a kind of programmed cell death that causes the release of damage-associated molecular patterns and inflammatory disease including skin inflammation. Activation of receptor-interacting serine/threonine kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) is the hallmark of tumour necrosis factor α (TNF ...
Jingyi Li   +13 more
openaire   +3 more sources

MLKL‒OPTN axis regulates herpesvirus‐induced neurological sequelae

open access: yesClinical and Translational Medicine
Background Herpes simplex virus‐1 (HSV‐1) infections are lifelong and linked to neurological diseases such as multiple sclerosis (MS), yet the underlying mechanisms in the host remain poorly understood.
Ilina Bhattacharya   +9 more
doaj   +1 more source

LUBAC-mediated M1 Ub regulates necroptosis by segregating the cellular distribution of active MLKL

open access: yesCell Death and Disease
Plasma membrane accumulation of phosphorylated mixed lineage kinase domain-like (MLKL) is a hallmark of necroptosis, leading to membrane rupture and inflammatory cell death.
Nadine Weinelt   +14 more
doaj   +1 more source

MLKL et les reliques de la mort

open access: yesmédecine/sciences, 2023
Gwennan André-Grégoire, Julie Gavard
openaire   +1 more source

MLKL in liver parenchymal cells promotes liver cancer in murine metabolic dysfunction-associated steatotic liver disease

open access: yesCell Death and Disease
The rising prevalence of hepatocellular carcinoma (HCC) in the last decade is mostly attributable to the growing epidemic of metabolic dysfunction-associated steatotic liver diseases (MASLD).
Ghiles Imerzoukene   +15 more
doaj   +1 more source

Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis [PDF]

open access: yes, 2015
Dieter Adam   +4 more
core   +1 more source

3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants [PDF]

open access: yes, 2015
Aggeliki-Stefania Basogianni   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy